Understanding Metastatic Carcinoma: Find key clinical documentation and medical coding resources for healthcare professionals. This comprehensive guide covers diagnosis, staging, treatment, and prognosis of metastatic cancer, including relevant ICD-10 codes, SNOMED CT concepts, and tumor markers. Learn about common sites of metastasis, treatment options like chemotherapy and immunotherapy, and palliative care considerations. Improve your understanding of metastatic carcinoma documentation and coding for accurate and efficient healthcare delivery.
Also known as
Secondary malignant neoplasm of specified sites
Cancers that have spread from a primary site to specific locations.
Malignant neoplasm without specification of site
Unspecified or unknown primary origin cancers, often metastatic.
Secondary malignant neoplasm of unspecified site
Cancer spread to an unknown location, with known primary origin.
Personal history of malignant neoplasm
Relevant for patients with a history of cancer, which could have metastasized.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the primary site of the cancer known?
When to use each related code
| Description |
|---|
| Metastatic Carcinoma |
| Carcinoma in Situ |
| Benign Neoplasm |
Missing primary site for metastatic carcinoma impacts accurate coding, staging, and treatment planning. CDI crucial for documentation.
Incorrect sequencing of primary and metastatic codes can lead to claim denials and affect quality reporting. Coding validation essential.
Discrepancy between histology and metastasis documentation risks coding errors. CDI should query physicians for clarification.
Patient presents with signs and symptoms suggestive of metastatic carcinoma. Clinical presentation includes [specific presenting symptoms e.g., fatigue, weight loss, pain at specific site, cough, dyspnea, etc.]. Physical examination reveals [objective findings e.g., palpable mass, lymphadenopathy, hepatomegaly, abnormal lung sounds, etc.]. Patient history includes [relevant past medical history, family history, social history e.g., smoking history, prior malignancy, family history of cancer]. Differential diagnosis includes primary [site] cancer with metastasis, secondary malignancy, and other conditions mimicking metastatic disease. Preliminary diagnostic workup includes [list diagnostic tests performed or ordered e.g., complete blood count, comprehensive metabolic panel, imaging studies such as CT scan, MRI, PET scan, biopsy, etc.]. Imaging studies indicate [specific findings from imaging e.g., presence of lesions, size and location of masses, evidence of lymphadenopathy, etc.]. Biopsy results, if available, show [histopathological findings confirming malignancy and specifying type e.g., adenocarcinoma, squamous cell carcinoma]. Based on the collective findings, the diagnosis of metastatic carcinoma is established. The primary site of origin is suspected to be [presumed primary site] based on [evidence supporting presumed primary site]. Staging workup is underway to determine the extent of metastatic disease. Treatment plan will be discussed with the patient and may include [potential treatment modalities e.g., chemotherapy, radiation therapy, targeted therapy, immunotherapy, surgery, palliative care]. Patient education provided regarding diagnosis, prognosis, treatment options, and potential side effects. Referral to oncology and other specialists as appropriate. Follow-up scheduled for [date and time] to discuss treatment plan and monitor response to therapy. ICD-10 code [appropriate ICD-10 code for specific metastatic carcinoma] is assigned. Medical billing codes for services rendered will be generated accordingly. This documentation supports medical necessity for procedures and treatments related to metastatic carcinoma management.